CID 504425
1-(2,4-difluoro-phenyl)-6-fluoro-7-(4-{2-fluoro-4-[5-(r)--(1-hydroxy-prop-2-inyl)-2-oxo-oxazolidin-3-yl]-phenyl}-piperazin-1-yl)-4-oxo-1,4-dihydro-[1,8] naphthyridine-3-carboxylic acid
Structural Information
- Molecular Formula
- C31H23F4N5O6
- SMILES
- C#CC([C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCN(CC3)C4=C(C=C5C(=O)C(=CN(C5=N4)C6=C(C=C(C=C6)F)F)C(=O)O)F)F)O
- InChI
- InChI=1S/C31H23F4N5O6/c1-2-25(41)26-15-39(31(45)46-26)17-4-6-23(21(34)12-17)37-7-9-38(10-8-37)29-22(35)13-18-27(42)19(30(43)44)14-40(28(18)36-29)24-5-3-16(32)11-20(24)33/h1,3-6,11-14,25-26,41H,7-10,15H2,(H,43,44)/t25?,26-/m1/s1
- InChIKey
- LKWOWBLSVQBJOD-FXDYGKIASA-N
- Compound name
- 1-(2,4-difluorophenyl)-6-fluoro-7-[4-[2-fluoro-4-[(5R)-5-(1-hydroxyprop-2-ynyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperazin-1-yl]-4-oxo-1,8-naphthyridine-3-carboxylic acid
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 638.16573 | 241.9 |
[M+Na]+ | 660.14767 | 250.4 |
[M-H]- | 636.15117 | 240.5 |
[M+NH4]+ | 655.19227 | 234.3 |
[M+K]+ | 676.12161 | 239.6 |
[M+H-H2O]+ | 620.15571 | 219.0 |
[M+HCOO]- | 682.15665 | 236.9 |
[M+CH3COO]- | 696.17230 | 241.5 |
[M+Na-2H]- | 658.13312 | 229.3 |
[M]+ | 637.15790 | 230.3 |
[M]- | 637.15900 | 230.3 |
Literature stripe
No literature data available for this compound.
Patent stripe
No patent data available for this compound.